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Energy metabolism is a very important process to improve and maintain health from the point of view of physiology. It is well
known that the intracellular ATP production is contributed to energy metabolism in cells.Cistus monspeliensis is widely used as tea,
spices, and medical herb; however, it has not been focusing on the activation of energy metabolism. In this study, C. monspeliensis
was investigated as the food resources by activation of energy metabolism in human intestinal epithelial cells. C. monspeliensis
extract showed high antioxidant ability. In addition, the promotion of metabolites of glycolysis and TCA cycle was induced by
C. monspeliensis treatment. These results suggest that C. monspeliensis extract has an ability to enhance the energy metabolism in
human intestinal cells.
1. Introduction
A lot of natural herbs distributed around the Mediterranean
Sea have been traditionally used by local people [1]. Most
of the studies on plants to grow for Mediterranean climate
have been investigated mainly in tolerance for the drying
and relationship with environmental stress. However, the
physiological function of natural herb is still poorly under-
stood though many species grow allover the place. In an
area of North Africa, the several species of natural herb were
employed in traditional medicine as active againstHelicobac-
ter pylori, oxidative stress, hypertension, and hypoglycaemic
[2–4]. Cistus monspeliensis is a perennial plant which in
widely distributed from South Europe to North Africa. The
genus Cistus is popular on tea and spice but not utilized for
the antiaging eﬀects. C. monspeliensis has been reported to
have an antioxidation, antibacterial, and anti-inflammatory
eﬀects [5].
In the small intestine, goblet cells secrete mucus that
forms a coating over the epithelial layer. The main function
of epithelial layer includes absorption of food compounds
[6]. The ingested capsaicin was carried into the intestinal
epithelium, which is in contact with a high concentration
of food ingredients [7, 8]. Considering the relevance of the
food components and the eﬀects of the oral route for human
exposure, we have investigated the eﬀect of capsaicin on the
energy metabolism of intestine, by using Caco-2 cell line, a
well-known in vitro model of intestinal epithelium [6].
The intracellular ATP accumulation is important for
optimal integrity of the mucosa and has been suggested to
play a specific role in the regulation of absorption and barrier
functions [9, 10]. From these reports, it was supposed that
the intracellular ATP accumulation contributes to the home-
ostasis of Caco-2 cells, because the regulation of absorption
and barrier functions are necessary for Caco-2 cells diﬀeren-
tiation [11].
In this study, the energymetabolism underlying the eﬀect
of C. monspeliensis extract on intestinal epithelium was clar-
ified by performing the capillary electrophoresis time-of-
flight mass spectrometry (CE-ToF/MS) analysis. Moreover,
we performed real-time PCR to quantitate mRNA using the
primers, related with ATP production, and the luciferase
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assay was performed to measure intracellular ATP produc-
tion in the intestinal epithelium. This is the first report that
the extract of C. monspeliensis was induced by the activation
of energy metabolism in human intestinal epithelial cells.
2. Materials and Methods
2.1. Cell Culture. Human intestinal epithelial Caco-2 cells
were obtained from American Type Culture Collection
(Manassas, VA, USA) and were used between passages 10 to
30. The cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM, Sigma, St. Louis, MO) supplemented with
10% (v/v) fetal bovine serum (Hyclone Co., Ltd.), 1% (v/v)
penicillin-streptomycin (Lonza, Walkersville, MDUSA), and
1% (v/v) nonessential amino acids (Cosmo Bio Co., Ltd.,
Tokyo, Japan) and incubated in an atmosphere of 5% CO2
at 37◦C.
2.2. Plant Materials and Extracts Preparation. 23 plants were
collected between June and July in 2008 from Jendouba,
Kairouan, and Kasserine areas in Tunisia and air-dried in
the shade at room temperature and ground to powder with
an electrical blender and stored at room temperature. Each
plant sample (1 g) was extracted with 10mL of distilled
water at 105◦C for 15 minutes or with 10mL of 70% (w/v)
ethanol at room temperature for 1 week. The extract water
was filtered and sterilized using 0.22 μmmembrane filter and
stored at −80◦C.
2.3. DPPH Assay. The antioxidant eﬀect of plants was deter-
mined by DPPH (1,1-diphenyl-2-picrylhydrazyl) assay
performed. DPPH (2mg) was dissolved in ethanol
(12.76mL). The ethanol solution (6mL), 400mM 2-mor-
pholinoethanesulfonic acid monohydrate (MES) solution
(1.5mL), and MilliQ water (4.5mL) were mixed in one tube.
Furthermore, plants extract (10 μL) and the mixing solution
(190 μL) were added in 96-well plates and incubated for
10min at room temperature. The absorbance was spectro-
photometrically determined at 520 nm using a multidetec-
tion microplate reader (Powerscan HT, Dainippon Pharma-
ceutical, USA).
2.4. Total RNA Isolation and Real-Time PCR. After incubat-
ing seeded plates for 24 h, total RNA was purified using the
ISOGEN kit (Nippon Gene Co., Ltd., Japan.) Total RNA was
quantified bymeasurement at 260 nmwith aUV spectropho-
tometer and was also measured at 280 nm to assess purity.
Only RNA with a 260/280 ratio higher than 1.8 was used
for the real-time PCR. Template cDNA was obtained from
total RNA using the SuperScript reverse transcriptase sys-
tem (Invitrogen). Briefly, RNA was denatured at 65◦C for
5min and incubated with 1mL oligo (dT) 12–15 primers
and chilled at 4◦C. After adding SuperScript II reverse tran-
scriptase (200 units), the reaction mix was incubated at 42◦C
for 60min, then 10min at 70◦C. For the quantification of
mRNA, nested primers were designed using Primer3Plus
software (http://www.bioinformatics.nl/cgi-bin/primer3plus/
primer3plus.cgi). Quantitative PCR reactions were per-
formed in a MiniOpticon instrument (Bio-Rad, USA).
Briefly, the RT mix (2mL) was used as template for the
real-time PCR mix containing 0.5mM forward and reverse
nested primers (2 μL each) and 2 × SYBR Green supermix
(10 μL). The primers used were checked using the BLASTn
program of the GeneBank; their sequence (TPI: forward:
5′-CTTGGCTGAGAGATGGAAGG-3′, reverse: 5′-CAG-
TGAAGGCAGACAAACCA-3′; PGM: forward: 5′-GCG-
GAGAACTTCATCCAGAG-3′, reverse: 5′-TGTCAGAAT-
GATCCCACCAA-3′; ATP synthase: forward: 5′-CTGGAG-
GACCTGTTGATGCT-3′, reverse: 5′-TGGGGTTTTTCG-
ATGACTTC-3′) was based on the known sequences in
the cording region of the human genes. The amplification
conditions were 3min at 95◦C, 10 sec at 95◦C, 30 sec at 62◦C,
and 30 sec 72◦C for 41 cycles. At the end of the reaction,
a melting curve analysis was carried out to check for the
presence of primer dimers.
2.5. Metabolomics Analysis. After incubating seeded plates
for 24 h, the extract was added at 0.1% (w/v) concentration
and the cells were incubated for 12 h. After treatment,
5% (w/w) mannitol solution was added at 10mL and was
removed. Once again, 5% (w/w) mannitol solution was
added at 2.0mL and was removed. Cells were scraped
in 1.3mL of methanol which includes 10 μM each of 2
internal standards (ISC1 and ISA1), and methanol including
scraped cells was transferred at 1.0mL to centrifuge tube.
1mL of chloroform and 400 μL of MilliQ water were added
to the solution and then thoroughly mixed. Followed by
centrifugation at 2,300 g for 5min at 4◦C, the 250 μL of
water layer was removed and centrifugally filtered through
a 5-kDa-cutoﬀ filter (Millipore, USA) to remove proteins.
The filtrate was desiccated and dissolved in 20 μL of MilliQ
water prior to injection. The capillary electrophoresis time-
of-flight mass spectrometry (CE-ToF/MS) experiments were
performed using an Agilent CE-ToF/MS system (Agilent
Technologies Co.) unit 5. Separations were carried out on a
fused silica capillary (50 μm i.d. × 80 cm total length). CE-
ToF/MS conditions for anionic metabolites were followed.
Run buﬀer: anion buﬀer solution (p/n: H3302-1021), rinse
buﬀer: anion buﬀer solution (p/n: H3302-1022), sample
injection: pressure injection 50mbar, 25 sec, CE voltage:
positive, 30 kV, MS ionization: ESI negative, MS capillary
voltage: 3,500 V, MS scan range: m/z 50–1,000, sheath liquid
(p/n: H3312-1020) [12].
2.6. ATP Measurement. ATP was assessed by firefly biolumi-
nescence using the luminescence luciferase assay kit (TOYO
Ink, Tokyo, Japan). Caco-2 cells were plated in 96-well plates
at 1.0 × 106 cells/mL in 100 μL. After 24 h incubation,
the extract was added at 0.1, 0.01, and 0.001% (w/v)
concentration, and the cells were incubated for 3, 6, and
12 h. After treatment, 100 μL of luciferin-luciferase solution
was added and stirred for 3min using a microplate genie,
100V (Scientific industries, Inc., USA). The luminescence
was determined using a multidetection microplate reader
(Powerscan HT, Dainippon Pharmaceutical, USA).
2.7. MTT Assay. The viability of cells was determined by
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
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bromide) assay. Briefly, Caco-2 cells were plated in 96-well
plates at 1.0 × 106 cells/mL in 100 μL. After 24 h incubation,
extract diluents with medium were added to obtain final
concentrations from 0.1% to 0.001% (w/v), and the cells
were cultured for 24 h, followed by the addition of 10 μL of
5.0mg/mL of MTT. After 12 h incubation, 150 μL of 10%
sodium dodecyl sulfate (Wako) was added and incubated
for 48 h. The absorbance was spectrophotometrically deter-
mined at 570 nm using a multidetection microplate reader
(Powerscan HT, Dainippon Pharmaceutical, USA).
3. Results
3.1. Eﬀect of Antioxidant of 23 Plants Extracts. DPPH radical
is well known as a stable organic free radical which has
been used for estimation of the antioxidant capacity. DPPH
radical is changed to nonradical to react antioxidants. We
determined the antioxidation of 23 plants grow around the
Mediterranean Sea. Especially, eighteen plants had higher
antioxidation more than 75% (Table 1). We selected C. mon-
speliensis in twenty three plants that had high antioxidation
to assess ATP production because this plant was used to
traditional foods.
3.2. Eﬀect of C. monspeliensis Extract on the Expression of
TPI, PGM, and ATP Synthase mRNA by Caco-2 Cells. To
investigate the eﬀect of C. monspeliensis extract on the acti-
vation of energy metabolism in human intestinal epithelium
(Figure 1), real-time PCR was employed to evaluate the
mRNA expression of genes, related with glycolysis and
TCA cycle. In this experiment, we used the primers of
triosephosphate isomerase (TPI), phosphoglycerate mutase
(PGM), and ATP synthase that have a deep relationship
with intracellular ATP production and relatively higher
expression in Caco-2 cells. Especially, to treat 0.1% (w/v)
C. monspeliensis for 6 h, mRNA expression levels of TPI,
PGM, and ATP synthase were upregulated by 170%, 161%,
and 310%, respectively. PGM is an enzyme that catalyzes
the internal transfer of a phosphate group from C-3 to
C-2 which results in the conversion of 3-phosphoglycerate
to 2-phosphoglycerate through a 2, 3-bisphosphoglycerate
intermediate. TPI is an enzyme that catalyzes the reversible
interconversion of the triose phosphate isomers, dihydroxy-
acetone phosphate, and D-glyceraldehyde 3-phosphate. TPI
plays an important role in glycolysis and is essential for
eﬃcient energy production. ATP synthase is an important
enzyme that creates energy for the cell to use through
the synthesis of ATP in mitochondria. In Figure 1, mRNA
expression of TPI and PGM, glycolytic enzymes, increased
to treat with C. monspeliensis extract. Also, ATP synthase,
electron transport chain enzyme, was increased.
3.3. Eﬀect of C. monspeliensis Extract on the Metabolomics
by Caco-2 Cells. As a result of the metabolomics analysis,
C. monspeliensis extraction increased production of each
metabolite in glycolysis and TCA cycle (Table 2). Glycolysis
is a pathway of ATP production in anaerobic. In this result,
three metabolites on rate-limiting step in glycolysis (glucose
6-phosphate, fructose 1,6-diphosphate, and pyruvic acid)
Table 1: Eﬀect of antioxidant of 23 plants extracts. The radical
2,2-diphenyl-1-picryhydrazyl (DPPH) was used for measuring the
antioxidants. The hot water extract and the ethanol extract were
diluted to 10 or 100 times by each solution. The values of
antioxidant were calculated by the following formula: antioxidant
(%) = {1−(Absorbance520 (Sample)/Absorbance520 (Control))}×
100.
Name of plants
EtOH extract
0.1% (w/v) 1% (w/v)
Ajuga iva 14 85
Artemisia campestris 38 91
Artemisia herba-alba 2 17
Cistus monspeliensis 24 93
Cyperus longus 10 50
Daphne gnidium 5 37
Erica multiflora 24 92
Globularia alypum 18 91
Laurus nobilis 10 54
Lavandula angustifolia 13 84
Lavandula oﬃcinalis 2 10
Lavandula stoechas 3 17
Marrubium vulgare 8 50
Mentha rotundifolia 8 43
Mentha viridis 12 71
Origanum majorana 13 85
Phillaria angustifolia 15 82
Pinus halepensis 11 53
Rhamnus lycioides 10 54
Teucrium polium 10 72
Thymus capitatus 13 87
Vitex agnus 13 78
Ziziphus lotus 15 76
were increased by C. monspeliensis extraction. Especially,
pyruvic acid was themost increased in glycolytic metabolites.
The production of pyruvic acid is related to promote
function of ATPase that involved ATP synthesis [13]. ATP is
not produced in TCA cycle; however, a lot of ATP is produced
in electron transport chain. Antiaging on promoting energy
metabolism is expected to promote function of glycolytic and
electron transport chain enzymes that are pathways of ATP
production.
3.4. Eﬀect of C. monspeliensis on the Intracellular ATP Pro-
duction by Caco-2 Cells. In the results of real-time PCR and
metabolomics, C. monspeliensis was upregulated metabolite
and mRNA expression involved ATP production. We deter-
mined ATP production of C. monspeliensis extract using
the luminescence luciferase assay kit (Figure 2). 0.1, 0.01,
and 0.001% (w/v) of C. monspeliensis extraction increased
ATP production on Caco-2 compared with nontreated cells.
Especially, to treat 0.01% (w/v) of C. monspeliensis for 3 h,
ATP production was upregulated by 172%. As a result, we
4 Journal of Biomedicine and Biotechnology
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Figure 1: Eﬀect of C. monspeliensis extract on the expression of TPI (a), PGM (b), and ATP synthase (c) mRNA by Caco-2 cells. β-actin was
used as a house-keeping gene. The mRNA expression of TPI, PGM, and ATP synthase was normalized by β-actin mRNA expression. Each
bar represents the mean ± SD (n = 3). ∗P < 0.05, ∗∗P < 0.01 compared to the control as determined by the t-test.
Table 2: Eﬀect of C. monspeliensis extract on the metabolomics by
Caco-2 cells. Quantified levels of metabolites involved in glycolysis
pathway were determined. Caco-2 cells were treated with 0.1%
(w/v) C. monspeliensis extract for 12 h. The ratio of quantified levels
of metabolites was calculated by Caco-2 cells treated or nontreated
with C. monspeliensis extract.
Metabolite Ratio
Glycolysis
Glucose 6-phosphate 1.7
Fructose 6-phosphate 1.6
Fructose 1,6-diphosphate 1.5
Dihydroxyacetone phosphate 2.1
3-Phosphoglyceric acid 1.0
Phosphoenolpyruvic acid 0.8
Pyruvic acid 4.2
TCA cycle
Acetyl CoA divalent 0.7
Citric acid 1.5
Cis-aconitic acid 1.4
Isocitric acid 1.0
2-Oxoglutaric acid 1.6
Succinic acid 0.8
Fumaric acid 1.1
Malic acid 1.0
considered that C. monspeliensis had eﬀect of ATP produc-
tion and to promote energy metabolism on Caco-2.
3.5. Eﬀect of C. monspeliensis on the Cell Viability by Caco-
2 Cells. We determined cell proliferation on Caco-2 using
MTT assay. From the result of MTT assay, 0.01 and 0.001%
(w/v) of C. monspeliensis extraction were not changed cell
proliferation on Caco-2 cells, whereas 0.1% (w/v) of C. mon-
speliensis extraction induced the increase of cell proliferation
on Caco-2 cells compared with nontreated cells. As a result,
we considered that 0.1 to 0.001% (w/v) C. monspeliensis
extract had not toxic eﬀect for Caco-2 cells.
4. Discussion
ATP is a multifunctional nucleotide that is the most
important as a “molecular currency” of intracellular energy
transfer. In this role, ATP transports chemical energy
within cells for metabolism. The glycolytic and TCA cyclic
enzymes played an important role in the intracellular ATP
production [14, 15]. TPI enzyme is essential for energy
production, allowing two molecules of glyceraldehyde 3-
phosphate to be produced for every glucose molecule,
thereby doubling the energy yield. PGM enzyme catalyzes
1,3-bisphosphoglycerate and plays an important role down-
stream of glycolysis. The activity of TPI and PGM was
not influenced by age or caloric restriction [16], while the
other glycolytic enzymes were influenced. Furthermore, the
activity and expression of these two enzymes, however, are
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decreased by oxidation and disorders (Alzheimer’s disease,
hemolytic anemia, erythrocyte destruction, etc.) [17, 18].
These observations indicate that the expression and activity
of these glycolytic enzymes were upregulated in response to
specific signals, such as C. monspeliensis extraction. Further-
more, ATP synthase contains a rotary motor involved in bio-
logical energy conversion. ATP synthase uses the proton mo-
tive force to make ATP from ADP and inorganic phosphate
(Pi) in mitochondria.
However, these enzymes have contribution toward not
only ATP production but also regulation of cellular function.
TPI isomerizes dihydroxy acetone phosphate (DHAP) to
glyceraldehydes 3-phosphate (GAP). Its deficiency has been
known to cause a severe multisystemic disease with autoso-
mal recessive inheritance [19] and neurodegeneration [20].
Decreased TPI activity induces the accumulation of DHAP,
which produces methylglyoxal instead of GAP. The methyl-
glyoxal induces oxidative damage to proteins and DNA and
accumulation of advanced glycation end products (AGEs),
which leads to structural degeneration and functional decline
of brain cells [21].
Also PGM is related with the apoptosis of human prostate
cancer cells, LNCaP, DU145, and PC-3 [22]. Monoubiqui-
tination of phosphoglycerate mutase, as well as formation
of a noncovalent complex containing ubiquitin and phos-
phoglycerate mutase, increased in colorectal cancer, which
may suggest a potential pathophysiological event [23]. A
decreased level of phosphoglycerate mutase isoenzymes was
reported in breast carcinoma [24] indicating its diﬀerential
expression.
Active regulation of the mitochondrial ATP-synthase
(complex V) in response to the cellular energy demand has
been demonstrated in several species like rat, dog, and hu-
mans and diﬀerent types of tissue like heart muscle, skeletal
muscle, fibroblasts, and brain. Regulation of the ATP-syn-
thase seems to be a central physiological phenomenon which
is presumably present in many other species and other
organs. As energy supply via themitochondrial ATP-synthase
plays such a vital role in almost every cell of the body,
more diseases will probably be identified where (primary or
secondary) abnormalities of this enzyme occur [25].
In addition, one of the causes of aging, free radical, is
focused on oxidative cytotoxic. Especially, oxidative cytotoxic
in mitochondrion is related to aging [26]. Mitochondrion
that is important as metabolism organ of ATP production
caused impairment accompanied eﬀect of aging and ROS.
Also, it is known that function of SOD decreased [27]. From
this paper, the eﬀect of enhancement component on ATP
production can make use of antiaging eﬀector as well as
functional foods for antiaging.
Our research showed that C. monspeliensis extract in-
duced the expression of enzymes, related with intracellular
ATP production, in human intestinal epithelial cells. And C.
monspeliensis extract enhanced the production of intracellu-
lar ATP. From these results, we suggest that C. monspeliensis
extract can be used as antiaging eﬀector. It is known that
species of Cistus contain quercetin, kaempferol, aesculin,
myricetin, and flavan-3-ols [28]. For example, quercetin has
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Figure 2: Eﬀect of C. monspeliensis extract on the intracellular ATP
production by Caco-2 cells. Caco-2 cells were treated with 0.1% to
0.001% (w/v) of C. monspeliensis extract for 3 h, 6 h, and 12 h. Each
bar represents the mean ± SD (n = 3). ∗P < 0.05, ∗∗P < 0.01
compared to the control as determined by the t-test.
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Figure 3: Eﬀect of C. monspeliensis extract on the cell viability by
Caco-2 cells. Caco-2 cells were treated with 0.1% to 0.001% (w/v)
of C. monspeliensis extract for 24 h. Each bar represents the mean
± SD (n = 3). ∗P < 0.05, ∗∗P < 0.01 compared to the control as
determined by the t-test.
antioxidation and has a function to improvememory impair-
ment that accompany Alzheimer’s disease [29]. Moreover,
it is known that an aging is caused for decline of intestinal
absorption [30, 31]. We expect that C. monspeliensis extract
can contribute to prevent several diseases like senescence,
Alzheimer’s disease, cardiosclerosis, stenocardia, cancer, and
so forth and recover the function of impairment intestinal
absorption.
0.001, 0.01% (w/v) of C. monspeliensis increased ATP
production (Figure 2) and, however, did not changed cell
viability as compared with control (Figure 3). On the other
hand, 0.1% (w/v) of C. monspeliensis decreased ATP pro-
duction as compared with low-concentration sample and,
however, up-regulated cell viability in MTT assay. From
these results, we considered that ATP was consumed for
cell proliferation in 0.1% (w/v) of C. monspeliensis, and
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ATP accumulation a little decreased as compared with low
concentration (0.01 and 0.001% (w/v)). It was reported that
the ATP accumulation was contributed to the proliferation
and homeostasis on Caco-2 cells [10]. We expect that C.
monspeliensis extract can induce the ATP accumulation and
then the activation of proliferation and homeostasis on
Caco-2 cells.
We considered that isolation of active component from
C. monspeliensis extract should be fulfilled and further in vivo
studies should focus on the confirmation of activation and
safety of C. monspeliensis extract.
5. Conclusion
Our findings indicate that C. monspeliensis extract had
high antioxidant ability. In addition, we show that C.
monspeliensis extract has the function of promoting energy
metabolism pathways, including glycolysis, TCA cycle, and
electron transport chain, in human intestinal epithelial cells.
Also, C. monspeliensis extract enhanced the production
of intracellular ATP on intestinal epithelium. From these
results, C. monspeliensis extract has an ability to enhance
the energy metabolism. Further studies are in progress to
elucidate the eﬀect of C. monspeliensis on antiaging.
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